Investigating how DNA repair defects affect inflammation and mitochondrial function in bacterial infections.

Linking defects in DNA polymerase beta to mitochondrial dysfunction and cytosolic nucleic acid sensor in Helicobacter pylori associated inflammation

NIH-funded research Howard University · NIH-10997333

This study is looking at how problems with a specific DNA repair enzyme might cause issues in our cells' energy factories, especially when someone has a Helicobacter pylori infection, and it hopes to help patients understand how these factors can lead to inflammation and health problems.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHoward University NIH-funded
Lab location1 site (Washington, United States)
Project IDNIH-10997333 on NIH RePORTER

What this research studies

This research focuses on understanding the relationship between defects in DNA polymerase beta and mitochondrial dysfunction, particularly in the context of Helicobacter pylori infections. The study examines how these defects can lead to increased inflammation and damage to mitochondrial DNA, which is crucial for maintaining cellular health. By analyzing the mechanisms of base excision repair, the research aims to uncover how these processes contribute to chronic inflammatory diseases. Patients may benefit from insights into how their immune responses are affected by bacterial infections and DNA repair deficiencies.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with chronic inflammatory conditions associated with Helicobacter pylori infections.

Not a fit: Patients without Helicobacter pylori infections or those not experiencing chronic inflammation may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for managing inflammation and mitochondrial dysfunction in patients with bacterial infections.

How similar studies have performed: Previous research has shown that targeting mitochondrial dysfunction can effectively improve outcomes in similar inflammatory conditions, suggesting a promising avenue for this study.

Where this research is happening

Washington, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.